Analyst Jim Molloy works at ALLIANCE GLOBAL PARTNERS and is focused on the Healthcare sector with 17 price targets and ratings documented since 2016 spanning on 3 stocks. Analyst's average stock valuation to be materialised ratio is 33.33% with an average time for price targets to be met of 15.67 days.
Most recent stock forecast was given on TNXP, Tonix Pharmaceuticals Holding Corp at 12-Jan-2023.
Jim Molloy best performing recommendations are on ICPT (INTERCEPT PHARMACEUTICALS, INC).
The best stock recommendation documented was for ICPT (INTERCEPT PHARMACEUTICALS, INC) at 5/5/2017. The price target of $115 was fulfilled within 3 days with a profit of $3.74 (3.15%) receiving and performance score of 10.5.
Average potential price target upside
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average time for PT to be met
Performance score
Buy
26
$7.6 (41.30%)
27
9 days ago
1/14 (7.14%)
$27.67 (69.79%)
90
Hold
14
$-4.4 (-23.91%)
16
2 months 13 days ago
2/2 (100%)
$-0.97 (-6.13%)
32
Hold
17
$-1.4 (-7.61%)
21
3 months 26 days ago
3/6 (50%)
$1.53 (25.80%)
99
Buy
35
$16.6 (90.22%)
52
3 months 26 days ago
3/18 (16.67%)
$134.4 (162.79%)
48
Buy
28
$9.6 (52.17%)
32
5 months 7 days ago
1/15 (6.67%)
$34.2 (68.57%)
9
